Adding checkpoint inhibition to anti-HER2 breast cancer therapy brings no benefit

Retrieved on: 2021-06-17 17:26:15

Tags for this article:

Click the tags to see associated articles and topics

Adding checkpoint inhibition to anti-HER2 breast cancer therapy brings no benefit. View article details on hiswai:

Excerpt

C.H. Barrios: Non-Financial Interests, Personal, Research Grant, Third-party writing support: F. Hoffmann-La Roche Ltd; Financial Interests, ...

Article found on: www.eurekalert.org